Because U.S. healthcare consumers aren’t influentially equipped and government interventions continue to be driven by a handful of powerful medical device and pharmaceutical suppliers, the market for healthcare cannot be analyzed using standard supply-and-demand curves. If you have any doubts, simply consider how U.S. hospitals have been effectively conditioned to expect higher prices, despite falling demand and reimbursements. click